Antisense & RNAi Therapeutics Global Market Report 2021 by The Business Research Company is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The chapter on the impact – both negative and positive – of COVID-19 on the antisense & RNAi therapeutics industry gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market. This includes revised market numbers according to the effects of the coronavirus and the expected antisense & RNAi therapeutics market growth numbers 2021-2030.

View Complete Report:
https://www.thebusinessresearchcompany.com/report/antisense-and-RNAi-therapeutics-market-global-report-2020-30-covid-19-growth-and-change

The Antisense & RNAi Therapeutics Global Market Report 2020-30 by The Business Research Company provides an in-depth analysis of the global antisense & RNAi therapeutics market and covers both the historic period, 2015 to 2020, and the forecast period, 2020 to 2030. The report evaluates the market and major economies across the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Antisense & RNAi Therapeutics Global Market Report 2021 covers antisense & RNAi therapeutics market drivers, antisense & RNAi therapeutics market trends, antisense & RNAi therapeutics market growth rate, antisense & RNAi therapeutics market major players, player-adopted strategies in the market, and antisense & RNAi therapeutics market size.

The global antisense & RNAi therapeutics market is expected to grow from $1.11 billion in 2020 to $1.2 billion in 2021 at a compound annual growth rate (CAGR) of 8.1%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $1.79 billion in 2025 at a CAGR of 11%.

Request For The Sample Now:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3389&type=smp

The report covers the antisense & RNAi therapeutics market segments-
1) By Technology: RNA Interference, Antisense RNA
2) By Route Of Administration: Pulmonary Delivery, Intravenous Injections, Intra-Dermal Injections, Intraperitoneal Injections, Topical Delivery, Other Delivery Methods
3) By Indication: Oncology, Cardiovascular Diseases (CVDs), Respiratory Disorders, Neurological Disorders, Infectious Diseases, Other

About The Business Research Company:
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology. It has offices in the UK, the US and India and a network of trained researchers in 20+ countries globally.

Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Blog: http://blog.tbrc.info/